AAAAAA

   
Results: 1-14 |
Results: 14
REDUCTION OF RELAPSES IN MULTIPLE-SCLEROSIS AFTER NATALIZUMAB (ANTEGREN) TREATMENT
Authors: SHEREMATA WA MINAGAR A HUME A KOLLER M VOLLMER T
Citation: Wa. Sheremata et al., REDUCTION OF RELAPSES IN MULTIPLE-SCLEROSIS AFTER NATALIZUMAB (ANTEGREN) TREATMENT, Annals of neurology, 44(3), 1998, pp. 257-257
A PLACEBO-CONTROLLED, SAFETY, TOLERABILITY, DOSE-ESCALATION, PK STUDYOF VARIOUS DOSES OF INTRAVENOUS ANTEGREN IN PATIENTS WITH MULTIPLE-SCLEROSIS (MS)
Authors: SHEREMATA WA VOLLMER TL STONE LA WILLMERHULME AJ KOLLER ME
Citation: Wa. Sheremata et al., A PLACEBO-CONTROLLED, SAFETY, TOLERABILITY, DOSE-ESCALATION, PK STUDYOF VARIOUS DOSES OF INTRAVENOUS ANTEGREN IN PATIENTS WITH MULTIPLE-SCLEROSIS (MS), Neurology, 50(4), 1998, pp. 4008-4008
CORRELATION OF ASHWORTH SCORE WITH AUTOMATED WARTENBERG PENDULUM MEASUREMENT OF QUADRICEPS SPASTICITY IN MULTIPLE-SCLEROSIS
Authors: SHEREMATA WA NANCE P SHELLENBERGER K
Citation: Wa. Sheremata et al., CORRELATION OF ASHWORTH SCORE WITH AUTOMATED WARTENBERG PENDULUM MEASUREMENT OF QUADRICEPS SPASTICITY IN MULTIPLE-SCLEROSIS, Annals of neurology, 42(3), 1997, pp. 286-286
ELEVATION OF PLATELET-LEUKOCYTE AGGREGATES (PAG) AND OF LEUKOCYTE ACTIVATION MARKER CD11B IN MULTIPLE-SCLEROSIS (MS)
Authors: SHEREMATA S JY W SHEREMATA WA HORSTMAN LL VALANT P AHN YS
Citation: S. Sheremata et al., ELEVATION OF PLATELET-LEUKOCYTE AGGREGATES (PAG) AND OF LEUKOCYTE ACTIVATION MARKER CD11B IN MULTIPLE-SCLEROSIS (MS), Blood, 90(10), 1997, pp. 2915-2915
RELATIONSHIP OF THE ANTISPASTICITY EFFECT OF TIZANIDINE TO PLASMA-CONCENTRATION IN PATIENTS WITH MULTIPLE-SCLEROSIS
Authors: NANCE PW SHEREMATA WA LYNCH SG VOLLMER T HUDSON S FRANCIS GS OCONNOR P COHEN JA SCHAPIRO RT WHITHAM R MASS MK LINDSEY JW SHELLENBERGER K
Citation: Pw. Nance et al., RELATIONSHIP OF THE ANTISPASTICITY EFFECT OF TIZANIDINE TO PLASMA-CONCENTRATION IN PATIENTS WITH MULTIPLE-SCLEROSIS, Archives of neurology, 54(6), 1997, pp. 731-736
ABSENCE OF PLATELET ACTIVATION IN MULTIPLE-SCLEROSIS WITH INTERFERON-BETA-1B TREATMENT
Authors: SHEREMATA WA KOLODNY L MARION F AHN Y
Citation: Wa. Sheremata et al., ABSENCE OF PLATELET ACTIVATION IN MULTIPLE-SCLEROSIS WITH INTERFERON-BETA-1B TREATMENT, Brain pathology, 6(3), 1996, pp. 357-357
EVIDENCE OF PLATELET ACTIVATION IN MULTIPLE-SCLEROSIS
Authors: KOLODNY L AHN Y SHEREMATA WA
Citation: L. Kolodny et al., EVIDENCE OF PLATELET ACTIVATION IN MULTIPLE-SCLEROSIS, Annals of neurology, 40(3), 1996, pp. 117-117
HTLV-II IN SEMINOLES - ASSOCIATION WITH DISEASE
Authors: SHEREMATA WA LOWIS GW WICKHAM P TORRONI A POIESZ B
Citation: Wa. Sheremata et al., HTLV-II IN SEMINOLES - ASSOCIATION WITH DISEASE, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 187-187
MORE ON INTERFERON-INDUCED CUTANEOUS NECROSIS - REPLY
Authors: SHEREMATA WA TAYLOR JR ELGART GW
Citation: Wa. Sheremata et al., MORE ON INTERFERON-INDUCED CUTANEOUS NECROSIS - REPLY, The New England journal of medicine, 333(18), 1995, pp. 1223-1224
SEVERE NECROTIZING CUTANEOUS LESIONS COMPLICATING TREATMENT WITH INTERFERON BETA-1B
Authors: SHEREMATA WA TAYLOR JR ELGART GW
Citation: Wa. Sheremata et al., SEVERE NECROTIZING CUTANEOUS LESIONS COMPLICATING TREATMENT WITH INTERFERON BETA-1B, The New England journal of medicine, 332(23), 1995, pp. 1584-1584
ASSOCIATION HTLV-II WITH NEUROLOGICAL DISEASE
Authors: SHEREMATA WA HARRINGTON WJ SNODGRASS SR BERGER JR POIESZ BJ
Citation: Wa. Sheremata et al., ASSOCIATION HTLV-II WITH NEUROLOGICAL DISEASE, AIDS research and human retroviruses, 10(4), 1994, pp. 480-480
STABILIZATION OF RELAPSING-REMITTING AND PROGRESSIVE MULTIPLE-SCLEROSIS WITH NATURAL INTERFERON-ALPHA - A PRELIMINARY TRIAL
Authors: SHEREMATA WA SQUILLACOTE D SAZANT A
Citation: Wa. Sheremata et al., STABILIZATION OF RELAPSING-REMITTING AND PROGRESSIVE MULTIPLE-SCLEROSIS WITH NATURAL INTERFERON-ALPHA - A PRELIMINARY TRIAL, Annals of neurology, 36(2), 1994, pp. 327-327
ASSOCIATION OF (TROPICAL) ATAXIC NEUROPATHY WITH HTLV-II
Authors: SHEREMATA WA HARRINGTON WJ BRADSHAW PA FOUNG SKH RAFFANTI SP BERGER JR SNODGRASS S RESNICK L POIESZ BJ
Citation: Wa. Sheremata et al., ASSOCIATION OF (TROPICAL) ATAXIC NEUROPATHY WITH HTLV-II, Virus research, 29(1), 1993, pp. 71-77
HIGH-DOSE ZIDOVUDINE INDUCTION IN HTLV-I-ASSOCIATED MYELOPATHY - SAFETY AND POSSIBLE EFFICACY
Authors: SHEREMATA WA BENEDICT D SQUILACOTE DC SAZANT A DEFREITAS E
Citation: Wa. Sheremata et al., HIGH-DOSE ZIDOVUDINE INDUCTION IN HTLV-I-ASSOCIATED MYELOPATHY - SAFETY AND POSSIBLE EFFICACY, Neurology, 43(10), 1993, pp. 2125-2129
Risultati: 1-14 |